For over a century, doctors have used electrocardiograms (EKGs) to render the invisible electrical activity of the human ...
How-To Geek on MSN
How to create professional-looking plots in Python
Use Python to make your data visualizations stand out.
A look inside Dataland in Los Angeles, dedicated entirely to A.I.-generated art. Refik Anadol, its founder, says it’s for ...
The Florida Python Challenge brings out a fascinating cast of characters, all captured by the director Xander Robin’s camera. By Alissa Wilkinson When you purchase a ticket for an independently ...
OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...
OpenAI explains in more detail what’s new with the GPT-5-class GPT-Realtime-2 voice model with reasoning: GPT‑Realtime‑2 is built for live voice interactions where the model keeps the conversation ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...
WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the agency to monitor clinical trial data in real time, a step the agency ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.
Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results